Evidence map›Paper›PMID 40757203›Full record

ArticleFrontiers in medicine2025

Development and validation of a prediction model based on a nomogram for tuberculous pleural effusion.

Suli Liu, Yao Yang, Dongmei Wang, Lijuan Gao, Jiangyue Qin, Yanqiu Wu, Diandian Li, Xiaohua Li, Mei Chen, Hao Wang and 3 more

Abstract read
In one paragraph

Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Suli Liu *Division of Pulmonary Diseases, State Key Laboratory of Biotherapy of China, Department of Respiratory and Critical Care Medicine, West China Hospital, Sichuan University, Chengdu, China.
Yao Yang *Division of Pulmonary Diseases, State Key Laboratory of Biotherapy of China, Department of Respiratory and Critical Care Medicine, West China Hospital, Sichuan University, Chengdu, China.
Dongmei Wang *Department of Medical Ultrasound, West China Hospital, Sichuan University, Chengdu, China.
Lijuan GaoDivision of Pulmonary Diseases, State Key Laboratory of Biotherapy of China, Department of Respiratory and Critical Care Medicine, West China Hospital, Sichuan University, Chengdu, China.
Jiangyue QinDivision of Pulmonary Diseases, State Key Laboratory of Biotherapy of China, Department of Respiratory and Critical Care Medicine, West China Hospital, Sichuan University, Chengdu, China.
Yanqiu WuDivision of Pulmonary Diseases, State Key Laboratory of Biotherapy of China, Department of Respiratory and Critical Care Medicine, West China Hospital, Sichuan University, Chengdu, China.
Diandian LiDivision of Pulmonary Diseases, State Key Laboratory of Biotherapy of China, Department of Respiratory and Critical Care Medicine, West China Hospital, Sichuan University, Chengdu, China.
Xiaohua LiDepartment of Respiratory and Critical Care Medicine, Sixth People's Hospital of Chengdu, Chengdu, China.
Mei ChenKey Laboratory of Acupuncture for Senile Disease (Chengdu University of TCM), School of Medical and Life Sciences, Chengdu University of Traditional Chinese Medicine, Ministry of Education, Chengdu, China.
Hao WangDivision of Pulmonary Diseases, State Key Laboratory of Biotherapy of China, Department of Respiratory and Critical Care Medicine, West China Hospital, Sichuan University, Chengdu, China.
Yongchun ShenDivision of Pulmonary Diseases, State Key Laboratory of Biotherapy of China, Department of Respiratory and Critical Care Medicine, West China Hospital, Sichuan University, Chengdu, China.
Fuqiang WenDivision of Pulmonary Diseases, State Key Laboratory of Biotherapy of China, Department of Respiratory and Critical Care Medicine, West China Hospital, Sichuan University, Chengdu, China.
Fangying ChenDepartment of Tuberculosis, The Third People's Hospital of Tibet Autonomous Region, Lhasa, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Diagnosing tuberculous pleural effusion (TPE) is challenging. There is a lack of cross-sectional lateral comparisons among TPE prediction models. Objectives: We aimed to develop and validate a novel TPE prediction model and compare its diagnostic performance with that of existing models. Methods: Patients with pleural effusion were included in the training, testing, and external validation sets. Variable selection strategies included LASSO and logistic regression. The discriminability, calibration, and clinical efficacy of the prediction model were estimated in the three sets. The performance of the model was compared with that of two existing prediction models. Results: Fever, tuberculosis interferon-gamma release assays, pleural adenosine deaminase, the pleural mononuclear cell ratio, the ratio of pleural lactate dehydrogenase to pleural adenosine deaminase, pleural carcinoembryonic antigen, and pleural cytokeratin 19 fragment were selected to establish the prediction model. The AUCs were 0.931 (0.903-0.958), 0.856 (0.753-0.959), and 0.925 (0.867-0.984) in the training, testing, and external validation sets, respectively. The AUCs of the two existing prediction models were 0.793 (0.737-0.850) and 0.854 (0.816-0.892). The calibration curves revealed that this model had good consistency. Decision curve analysis revealed the acceptable clinical benefit of this model. Conclusion: Compared with the existing models, the TPE prediction model developed in this study demonstrated good diagnostic performance.

Indexed as

clinical prediction modeldiagnosisnomogramtuberculosistuberculous pleural effusion

Identifiers

PMID40757203
PMCPMC12313491

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.